This Government Contract opportunity from Department Of Defense was posted on May 8, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
Pharmaceutical Manufacturing and Supply
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
This contract involves the manufacture and supply of pharmaceutical tablets containing 1 MG Norethindrone and 20 MCG Ethinyl Estradiol. The tablets are to be packaged as 21 tablets per cycle with 5 cycles in each package, totaling 105 tablets per unit. The production must comply with FDA and Department of Defense Logistics Agency (DLA) technical standards, ensuring quality and regulatory adherence. Issued by the Department of Defense's Medical Supply Chain Pharmacy FSA, the subcontract falls under NAICS code 325412, which relates to pharmaceutical manufacturing. The solicitation was posted on May 8, 2026, with responses due by May 13, 2026. Specific location details and points of contact were not provided. The contract seeks a qualified supplier capable of meeting stringent regulatory requirements to support medical supply needs.
General Info
Agency
NAICS
Place of Performance
USSet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Submission Closed
